31 March 2022
Our CAR T-cell Research Team talks to Claire Concannon from RNZ's Our Changing World about how we're building the future of cancer treatment in New Zealand.
Dr Patricia Rubio-Reyes, PhD Student Yasmin Nouri and Dr Rachel Perret are part of the Malaghan Institute's Freemasons CAR T-cell Research Programme. Their work, running in parallel to the Institute's CAR T-cell clinical trial, aims to both better understand this groundbreaking therapy at the molecular level, as well as develop ways to improve its safety and widen the scope of the therapy to treat more cancers in the future.
Related articles
New Zealand to New York and back again: Malaghan researcher tackling liver cancer
18 November 2024
Read more
Community partnerships: Zephyr Consulting empowering emerging scientific talent
18 November 2024
Read more
In Focus: CAR T-cell therapy, the battle of the blood cells
26 September 2024
Read more
In Focus: CAR T-cell therapy, the battle of the blood cells
26 September 2024
Read more
Phase 2 clinical trial underway to confirm effectiveness and safety of NZ’s first CAR T-cell cancer therapy
23 July 2024
Read more
Phase 2 clinical trial underway to confirm effectiveness and safety of NZ’s first CAR T-cell cancer therapy
23 July 2024
Read more